Smalberg, J.H.

patient thrombosis study factor venou portal vein thrombosis venous thrombosis portal mutation budd-chiari syndrome jak 2v risk factors blood splanchnic vein thrombosis fibrinogen level syndrome chapter jak 2v mutation myeloproliferative budd-chiari pvt patients liver treatment disorder splanchnic svt patients therapy disease diagnosis control thromb venous thromboembolism 46/1 ratio haplotype bcs patients risk factor follow-up prevalence etiology result thrombolytic therapy haemost thromboembolism complication association survival neoplasm leebeek fw prothrombotic cohort vein thrombosis difference development thrombotic janssen myeloproliferative neoplasms rosendaal fr event myeloproliferative disorders thrombolytic deficiency polycythemia vera protein portal hypertension leebeek cause janssen hl count ënten hepatic table leiden valla dc criteria valla analysis cirrhosis hepatology